Background: As a substudy of the large, randomized LONG-DES-III and IV (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III and IV) trials comparing sirolimus-eluting stents (SES), everolimus-eluting stents (EES) and zotarolimus-eluting stents (ZES), we sought to investigate intimal hyperplasia (IH) and vascular changes using volumetric intravascular ultrasound analysis Methods: Complete angiographic and volumetric intravascular ultrasound data immediately after stenting and at 9-month follow-up were available in 259 patients with 259 lesions (130 SES, 61 EES and 68 ZES). External elastic membrane (EEM), stent, lumen, and peristent plaque volumes (external elastic membrane minus stent) were normalized by stent length. Results: Normalized IH volume was greater in EES than SES (0.7Ϯ0.4 mm 2 vs. 0.5Ϯ0.4 mm
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Background: Percutaneous coronary intervention carries a risk of dissections at the edges of the implanted stent. Optical coherence tomography (OCT) enables detection and detailed characterization of edge dissections (ED). We investigated the incidence, predictors and outcome of OCT detected EDs. Methods: All patients with OCT evaluation at baseline and 12-month follow-up (FU) in the SORT-OUT V OCT substudy were included in the analysis. Plaques present in the edge segments 5 mm proximal and distal to the study stent were characterized by plaque type. All EDs were characterized by size and underlying plaque type. Results: A total of 123 patients were included in the OCT substudy. Of these, 23 were not available for analysis due to patient drop out, contraindication to the FU OCT or poor image quality. No baseline EDs were found in three coronary event patients with no OCT FU. One patient with stent thrombosis (ST) within 2 hours had ED in a fibroatheroma. In the 97 patients included in the analysis 177 edges were visualized by OCT. A total of 37 (20.1%) EDs were detected in 33 patients (34% of patients). Size of EDs were longitudinal length: 1.90Ϯ0.97 mm, transversal length: 1.12Ϯ0.61 mm, and distance from tip of flap to vessel wall was 0.31Ϯ0.18 mm. Edge tissue characteristics for the analyzed edges were fibrotic plaques 94 (53.1%), calcific plaques 11 (6.2%), 25 lipid plaques (14.1%), and 47 (26.6%) edge segments with normal tissue. EDs occurred in fibrotic plaques in 28 (15.8%), 6 (3.3%) in fibrocalcific plaques and 3 (1.7%) in lipid plaques. None of the EDs were visible on XA. Two EDs were partially healed at 12 month FU, one located in a residual stenosis after stenting. At FU the stenosis had progressed to clinical significance. Conclusions: Coronary EDs undetectable by XA were identified by OCT in 34% of the study population and left untreated. One ED over a fibroatheroma may have caused acute ST. All other EDs were completely or almost healed at 12 months FU. These results do not support additional intervention when EDs in fibrotic or fibrocalcific plaques are detected by OCT only. 
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